Pulmonary tumor embolism: A retrospective study over a 30-year period.

<h4>Background</h4>Pulmonary tumor embolism (PTE) is difficult to detect before death, and it is unclear whether the discrepancy between antemortem clinical and postmortem diagnosis improves with the advance of the diagnostic technologies. In this study we determined the incidence of PTE...

Full description

Bibliographic Details
Main Authors: Xin He, Douglas C Anthony, Zulmira Catoni, Weibiao Cao
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0255917
id doaj-5d903cdc903a4c5b852f204064e42669
record_format Article
spelling doaj-5d903cdc903a4c5b852f204064e426692021-08-17T04:30:56ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01168e025591710.1371/journal.pone.0255917Pulmonary tumor embolism: A retrospective study over a 30-year period.Xin HeDouglas C AnthonyZulmira CatoniWeibiao Cao<h4>Background</h4>Pulmonary tumor embolism (PTE) is difficult to detect before death, and it is unclear whether the discrepancy between antemortem clinical and postmortem diagnosis improves with the advance of the diagnostic technologies. In this study we determined the incidence of PTE and analyzed the discrepancy between antemortem clinical and postmortem diagnosis.<h4>Methods</h4>We performed a retrospective autopsy study on patients with the history of malignant solid tumors from 1990 to 2020 and reviewed all the slides of the patients with PTE. We also analyzed the discrepancies between antemortem clinical and postmortem diagnosis in 1999, 2009 and 2019 by using the Goldman criteria. Goldman category major 1 refers to cases in which an autopsy diagnosis was the direct cause of death and was not recognized clinically, but if it had been recognized, it may have changed treatment or prolonged survival.<h4>Results</h4>We found 20 (3%) cases with PTE out of the 658 autopsy cases with solid malignancies. Out of these 20 cases, urothelial carcinoma (30%, 6/20) and invasive ductal carcinoma of the breast (4/20, 20%) were the most common primary malignancies. Seven patients with shortness of breath died within 3-17 days (average 8.4±2.2 days) after onset of the symptoms. Pulmonary embolism was clinically suspected in seven out of twenty (35%, 7/20) patients before death, but only two patients (10, 2/20) were diagnosed by imaging studies before death. The rate of Goldman category major 1 was 13.2% (10/76) in 1999, 7.3% (4/55) in 2009 and 6.9% (8/116) in 2019. Although the rate of Goldman category major 1 appeared decreasing, the difference was not statistically significant. The autopsy rate was significantly higher in 2019 (8.4%, 116/1386) than in 2009 (4.4%, 55/1240).<h4>Conclusions</h4>The incidence of PTE is uncommon. Despite the advances of the radiological techniques, radiological imaging studies did not detect the majority of PTEs. The discrepancy between the antemortem clinical and the postmortem diagnosis has not improved significantly over the past 30 years, emphasizing the value of autopsy.https://doi.org/10.1371/journal.pone.0255917
collection DOAJ
language English
format Article
sources DOAJ
author Xin He
Douglas C Anthony
Zulmira Catoni
Weibiao Cao
spellingShingle Xin He
Douglas C Anthony
Zulmira Catoni
Weibiao Cao
Pulmonary tumor embolism: A retrospective study over a 30-year period.
PLoS ONE
author_facet Xin He
Douglas C Anthony
Zulmira Catoni
Weibiao Cao
author_sort Xin He
title Pulmonary tumor embolism: A retrospective study over a 30-year period.
title_short Pulmonary tumor embolism: A retrospective study over a 30-year period.
title_full Pulmonary tumor embolism: A retrospective study over a 30-year period.
title_fullStr Pulmonary tumor embolism: A retrospective study over a 30-year period.
title_full_unstemmed Pulmonary tumor embolism: A retrospective study over a 30-year period.
title_sort pulmonary tumor embolism: a retrospective study over a 30-year period.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2021-01-01
description <h4>Background</h4>Pulmonary tumor embolism (PTE) is difficult to detect before death, and it is unclear whether the discrepancy between antemortem clinical and postmortem diagnosis improves with the advance of the diagnostic technologies. In this study we determined the incidence of PTE and analyzed the discrepancy between antemortem clinical and postmortem diagnosis.<h4>Methods</h4>We performed a retrospective autopsy study on patients with the history of malignant solid tumors from 1990 to 2020 and reviewed all the slides of the patients with PTE. We also analyzed the discrepancies between antemortem clinical and postmortem diagnosis in 1999, 2009 and 2019 by using the Goldman criteria. Goldman category major 1 refers to cases in which an autopsy diagnosis was the direct cause of death and was not recognized clinically, but if it had been recognized, it may have changed treatment or prolonged survival.<h4>Results</h4>We found 20 (3%) cases with PTE out of the 658 autopsy cases with solid malignancies. Out of these 20 cases, urothelial carcinoma (30%, 6/20) and invasive ductal carcinoma of the breast (4/20, 20%) were the most common primary malignancies. Seven patients with shortness of breath died within 3-17 days (average 8.4±2.2 days) after onset of the symptoms. Pulmonary embolism was clinically suspected in seven out of twenty (35%, 7/20) patients before death, but only two patients (10, 2/20) were diagnosed by imaging studies before death. The rate of Goldman category major 1 was 13.2% (10/76) in 1999, 7.3% (4/55) in 2009 and 6.9% (8/116) in 2019. Although the rate of Goldman category major 1 appeared decreasing, the difference was not statistically significant. The autopsy rate was significantly higher in 2019 (8.4%, 116/1386) than in 2009 (4.4%, 55/1240).<h4>Conclusions</h4>The incidence of PTE is uncommon. Despite the advances of the radiological techniques, radiological imaging studies did not detect the majority of PTEs. The discrepancy between the antemortem clinical and the postmortem diagnosis has not improved significantly over the past 30 years, emphasizing the value of autopsy.
url https://doi.org/10.1371/journal.pone.0255917
work_keys_str_mv AT xinhe pulmonarytumorembolismaretrospectivestudyovera30yearperiod
AT douglascanthony pulmonarytumorembolismaretrospectivestudyovera30yearperiod
AT zulmiracatoni pulmonarytumorembolismaretrospectivestudyovera30yearperiod
AT weibiaocao pulmonarytumorembolismaretrospectivestudyovera30yearperiod
_version_ 1721205535898861568